-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Glycomimetics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2024.
- Glycomimetics Inc Operating Income (Loss) for the quarter ending December 31, 2024 was -$7.33M, a 23.5% increase year-over-year.
- Glycomimetics Inc Operating Income (Loss) for the twelve months ending December 31, 2024 was -$40M, a 1.95% decline year-over-year.
- Glycomimetics Inc annual Operating Income (Loss) for 2024 was -$40M, a 1.95% decline from 2023.
- Glycomimetics Inc annual Operating Income (Loss) for 2023 was -$39.3M, a 17.1% increase from 2022.
- Glycomimetics Inc annual Operating Income (Loss) for 2022 was -$47.4M, a 25.3% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)